Improving treatment and survival: A population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer

HPB

Volumn 17, Issue 11, 2015, Pages 1019-1024

  Zaydfudim, Victor M ^a,b   McMurry, Timothy L ^b   Harrigan, Amy M ^a,b   Friel, Charles M ^a   Stukenborg, George J ^b   Bauer, Todd W ^a   Adams, Reid B ^a   Hedrick, Traci L ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; ICD-9-CM; LIVER CANCER; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; RISK REDUCTION; ADENOCARCINOMA; CANCER REGISTRY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; INCIDENCE; LIVER NEOPLASMS; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSTOPERATIVE PERIOD; PROCEDURES; SECONDARY; SURVIVAL RATE; TRENDS; VIRGINIA;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; VIRGINIA;

EID: 84943819869     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12488     Document Type: Article

References (25)

1. Mayo SC, Pawlik TM,. (2009) Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol 3: 131-144.
2. Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al,. (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17: 1225-1239.
3. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al,. (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27: 3677-3683.
4. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, et al,. (2009) Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB 11: 510-515.
5. Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF,. (2009) In-hospital mortality for liver resection for metastases: a simple risk score. J Surg Res 156: 21-25.
6. Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA,. (2014) Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB 16: 459-468.
7. Cummings LC, Payes JD, Cooper GS,. (2007) Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109: 718-726.
8. Bartlett EK, Simmons KD, Wachtel H, Roses RE, Fraker DL, Kelz RR, et al,. (2015) The rise in metastasectomy across cancer types over the past decade. Cancer 121: 747-757.
9. Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK, Rimm AA,. (1999) The utility of Medicare claims data for measuring cancer stage. Med Care 37: 706-711.
10. Whyte JL, Engel-Nitz NM, Teitelbaum A, Gomez Rey G, Kallich JD,. (2015) An evaluation of algorithms for identifying metastatic breast, lung, or colorectal cancer in administrative Claims data. Med Care 53: e49-e57.
11. Nordstrom BL, Whyte JL, Stolar M, Mercaldi C, Kallich JD,. (2012) Identification of metastatic cancer in claims data. Pharmacoepidemiol Drug Saf 21 (Suppl. 2): 21-28.
12. Deyo RA, Cherkin DC, Ciol MA,. (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619.
13. Klabunde CN, Warren JL, Legler JM,.(2002) Assessing comorbidity using claims data: an overview. Med Care 40:IV-26-35.
14. Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D,. (2004) Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 22: 3475-3484.
15. Parikh AA, Ni S, Koyama T, Pawlik TM, Penson D,. (2013) Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy. J Gastrointest Surg 17: 1938-1946.
16. Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al,. (2012) Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4: 283-301.
17. Vargas GM, Parmar AD, Sheffield KM, Tamirisa NP, Brown KM, Riall TS,. (2014) Impact of liver-directed therapy in colorectal cancer liver metastases. J Surg Res 191: 42-50.
18. Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, et al,. (2014) Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care 52: e65-e73.
19. Scheele J, Stang R, Altendorf-Hofmann A, Paul M,. (1995) Resection of colorectal liver metastases. World J Surg 19: 59-71.
20. Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, et al,. (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97: 1110-1118.
21. Parikh AA, Robinson J, Zaydfudim VM, Penson D, Whiteside MA,. (2014) The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer. J Surg Oncol 110: 227-232.
22. Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN,. (2011) Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB 13: 774-782.
23. Bartlett DL, Chu E,. (2012) Can metastatic colorectal cancer be cured? Oncology (Williston Park) 26: 266-275.
24. Chua TC, Liauw W, Chu F, Morris DL,. (2012) Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol 35: 77-80.
25. Abdalla EK, Bauer TW, Chun YS, D'Angelica M, Kooby DA, Jarnagin WR,. (2013) Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB 15: 119-130.